Longitudinal Course of Clinical Lung Clearance Index in Children with Cystic Fibrosis.
Options
BORIS DOI
Publisher DOI
PubMed ID
33361098
Description
RATIONALE
While lung clearance index (LCI) is a sensitive marker of small airway disease in individuals with cystic fibrosis (CF), less is known about longitudinal changes in LCI during routine clinical surveillance.
OBJECTIVES
To describe the longitudinal course of LCI in children with CF during routine clinical surveillance and assess influencing factors.
METHODS
Children with CF aged 3-18 years performed LCI measurements every 3 months as part of routine clinical care between 2011 and 2018. We recorded clinical data at every visit. We used a multilevel mixed-effect model to determine changes in LCI over time and identify clinical factors that influence LCI course.
MEASUREMENTS AND MAIN RESULTS
We collected LCI from 1204 visits (3603 trials) in 78 participants, of which 907 visits had acceptable LCI data. The average unadjusted increase in LCI for the entire population was 0.29 LCI units·year-1 (95% CI 0.20-0.38). The increase in LCI was more pronounced in adolescence, with 0.41 units·year-1 (95% CI 0.27-0.54). Colonisation with either Pseudomonas aeruginosa or Aspergillus fumigatus, pulmonary exacerbations, CF-related diabetes, and bronchopulmonary aspergillosis were associated with a higher increase in LCI over time. Adjusting for clinical risk factors reduced the increase in LCI over time to 0.24 LCI units·year-1 (95% CI 0.16-0.33).
CONCLUSION
LCI measured during routine clinical surveillance is associated with underlying disease progression in children with CF. An increased change in LCI over time should prompt further diagnostic intervention.
While lung clearance index (LCI) is a sensitive marker of small airway disease in individuals with cystic fibrosis (CF), less is known about longitudinal changes in LCI during routine clinical surveillance.
OBJECTIVES
To describe the longitudinal course of LCI in children with CF during routine clinical surveillance and assess influencing factors.
METHODS
Children with CF aged 3-18 years performed LCI measurements every 3 months as part of routine clinical care between 2011 and 2018. We recorded clinical data at every visit. We used a multilevel mixed-effect model to determine changes in LCI over time and identify clinical factors that influence LCI course.
MEASUREMENTS AND MAIN RESULTS
We collected LCI from 1204 visits (3603 trials) in 78 participants, of which 907 visits had acceptable LCI data. The average unadjusted increase in LCI for the entire population was 0.29 LCI units·year-1 (95% CI 0.20-0.38). The increase in LCI was more pronounced in adolescence, with 0.41 units·year-1 (95% CI 0.27-0.54). Colonisation with either Pseudomonas aeruginosa or Aspergillus fumigatus, pulmonary exacerbations, CF-related diabetes, and bronchopulmonary aspergillosis were associated with a higher increase in LCI over time. Adjusting for clinical risk factors reduced the increase in LCI over time to 0.24 LCI units·year-1 (95% CI 0.16-0.33).
CONCLUSION
LCI measured during routine clinical surveillance is associated with underlying disease progression in children with CF. An increased change in LCI over time should prompt further diagnostic intervention.
Date of Publication
2021-07
Publication Type
Article
Subject(s)
600 - Technology::610 - Medicine & health
300 - Social sciences, sociology & anthropology::360 - Social problems & social services
Language(s)
en
Contributor(s)
Additional Credits
Universitätsklinik für Kinderheilkunde
Institut für Sozial- und Präventivmedizin (ISPM)
Series
European respiratory journal
Publisher
European Respiratory Society
ISSN
0903-1936
Access(Rights)
open.access